MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transport. [electronic resource]
Producer: 20110801Description: 24-34 p. digitalISSN:- 1873-2968
- ATP Binding Cassette Transporter, Subfamily G, Member 2
- ATP-Binding Cassette Transporters -- metabolism
- Antineoplastic Agents -- pharmacology
- Benzimidazoles -- metabolism
- Biological Transport -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Drug Screening Assays, Antitumor
- Drug Synergism
- Drug Therapy, Combination
- Fluorescent Dyes -- metabolism
- Humans
- Imidazoles -- pharmacology
- Mitoxantrone -- pharmacology
- Neoplasm Proteins -- metabolism
- Osteosarcoma -- drug therapy
- Piperazines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.